Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Deoxynucleoside analogues such as 5-aza-2-deoxycytidine (depicted by Z) are converted into the triphosphate inside S-phase cells and are incorporated in place of cytosine into DNA. Ribonucleosides ...

Donna Johnstone is living with chronic kidney disease after taking a popular medication for reflux for 20 years.

Semaglutide injections effectively support weight loss by regulating appetite and glucose levels, offering benefits for ...

A common immunotherapy approach helped stave off disease progression in patients with a form of anal cancer that is caused by ...

Researchers from Johnson & Johnson presented the discovery of a novel inhibitor of cyclin-dependent kinase 7 (CDK7), a ...

0:09 | NKT-2152 is a HIF-2α inhibitor, so it will bind to HIF-2α to prevent heterodimerization with HIF-1 beta. And this is ...

In an international multicenter randomized phase 3 clinical trial led by Dana-Farber Cancer Institute, researchers tested the ...

New data suggest that current recommendations overstate the proportion of patients who would receive significant kidney ...

The firm is testing azenosertib as a single agent and in combination with other drugs in various solid tumors and looking at response biomarkers.

The company has identified an optimal dose and potential biomarkers of response to PRTH-101 in the Phase I trial.